McDermott International, Inc. (MDRIQ)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In McDermott International, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in McDermott International, Inc. ("McDermott" or the "Company")(OTC:MDRIQ) of the September 16, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against executives of the Company.

If you invested in McDermott stock or options between September 20, 2019 and January 23, 2020 and would like to discuss your legal rights, please fill out the form below. There is no cost or obligation to you. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to

The lawsuit has been filed in the U.S. District Court for the Southern District of Texas on behalf of all those who purchased McDermott securities between September 20, 2019 and January 23, 2020 (the "Class Period"). The case, Ahnefeldt et al. v. Dickson et al., No. 20-cv-02539 was filed on July 17, 2020, and has been assigned to Judge George C. Hanks, Jr..

The lawsuit focuses on whether the Company’s executives violated federal securities laws by failing to disclose that Defendants knowingly and/or recklessly made, and caused McDermott to make materially false and misleading statements, and/or omit material facts regarding the sale of certain assets of McDermott. These statements were made with the intent to conceal the acute liquidity crisis McDermott actually faced, provide the Company time to prepare a prepackaged plan of reorganization with its secured lenders and other stakeholders, and avoid a freefall Chapter 11 filing.

Specifically, on September 20, 2019, McDermott announced in a press release its recent receipt of unsolicited approaches to acquire Lummus Technology, McDermott’s industry leading technology business with a valuation exceeding $2.5 billion. McDermott told investors that it was "exploring strategic alternatives to unlock the value of Lummus Technology," that the "process of exploring strategic alternatives is part of our ongoing efforts intended to improve McDermott’s capital structure," and "we plan to use the proceeds from any transaction involving Lummus Technology to strengthen our balance sheet." These disclosures received widespread attention and the price for McDermott common stock increased.

Then, on January 21, 2020, the truth emerged when McDermott announced its entry of a Restructuring Support Agreement in connection with a Joint Prepackaged Chapter 11 Plan of Reorganization. In the plan documents, it was revealed that there was not any plan for a near-term sale of Lummus Technology to strengthen McDermott’s balance sheet. The disclosures were made as part of a scheme to artificially inflate the market price of McDermott’s common stock, calm the market and allow the Company to negotiate a prepackaged Chapter 11 bankruptcy restructuring plan.

On this news, McDermott’s share price fell from $0.70 per share on January 17, 2020 to a closing price of $0.12 on January 23, 2020: a $0.58 or an 82.81% drop.

Contact us

McDermott International, Inc. (MDRIQ)

Loading captcha, please wait...

* The submission of this form does not create an attorney-client relationship.


Filed on 07/20/2020


Lead Plaintiff Deadline 09/16/2020


685 Third Avenue 26th Floor

10017 New York, New York

Phone (212) 983-9330

Fax (212) 983-9331


Richard W. Gonnello Phone (212) 983-9330 Fax (212) 983-9331

Finding us

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331


10866 Wilshire Boulevard Suite 1470
Los Angeles, California 90024
(424) 256-2884
(424) 256-2885


3828 Kennett Pike Suite 201
Wilmington, Delaware 19807
(302) 482-3182
(302) 482-3612


3975 Roswell Rd Suite A
Atlanta, Georgia 30342
(404) 847-0617
(404) 506-9534


1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Wilmington, Delaware

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania